A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 7, 2008

Primary Completion Date

July 30, 2008

Study Completion Date

July 30, 2008

Conditions

Influenza

Interventions

BIOLOGICAL

Fluarix™

Single intramuscular dose on Day 0

Trial Locations (5)

GSK Investigational Site, Dresden

GSK Investigational Site, Dresden

GSK Investigational Site, Dresden

GSK Investigational Site, Dresden

GSK Investigational Site, Freital